| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adverse Events Associated with Encorafenib Plus Cetuximab in Patients with BRAFV600E-mutant Metastatic Colorectal Cancer: An in-depth Analysis of the BEACON CRC Study
|
Taieb, Julien
|
|
|
22 |
1 |
p. 59-66
|
article
|
| 2 |
An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World Study
|
Nie, Caiyun
|
|
|
22 |
1 |
p. 76-84
|
article
|
| 3 |
Cancers of the Pancreas Update 2023
|
Berlin, Jordan
|
|
|
22 |
1 |
p. 1
|
article
|
| 4 |
CT-guided Radioactive 125I Seed Implantation for Abdominal Incision Metastases of Colorectal Cancer: Safety and Efficacy in 17 Patients
|
Wang, Hao
|
|
|
22 |
1 |
p. 136-142
|
article
|
| 5 |
Editorial Board
|
|
|
|
22 |
1 |
p. A1
|
article
|
| 6 |
GI Symptoms in Pancreatic Cancer
|
Chang, Victor T.
|
|
|
22 |
1 |
p. 24-33
|
article
|
| 7 |
Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer
|
Altshuler, Ellery
|
|
|
22 |
1 |
p. 153-159
|
article
|
| 8 |
Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer
|
ten Hoorn, Sanne
|
|
|
22 |
1 |
p. 67-75
|
article
|
| 9 |
Molecular Residual Disease-guided Adjuvant Treatment in Resected Colorectal Cancer: Focus on CIRCULATE-Japan
|
Sato, Seiya
|
|
|
22 |
1 |
p. 53-58
|
article
|
| 10 |
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
|
Shah, Manish A.
|
|
|
22 |
1 |
p. 100-110
|
article
|
| 11 |
Pathologic Implications of Magnetic Resonance Imaging-detected Extramural Venous Invasion of Rectal Cancer
|
Lee, Hyun Gu
|
|
|
22 |
1 |
p. 129-135
|
article
|
| 12 |
ROCKET: Phase II Randomized, Active-controlled, Multicenter Trial to Assess the Safety and Efficacy of RRx-001 + Irinotecan vs. Single-agent Regorafenib in Third/Fourth Line Colorectal Cancer
|
Reid, Tony R.
|
|
|
22 |
1 |
p. 92-99
|
article
|
| 13 |
Sarcopenia is Associated With Oncological Prognosis and the Incidence of Secondary Cancer in Patients With Middle/Lower Rectal Cancer
|
Abe, Shinya
|
|
|
22 |
1 |
p. 143-152
|
article
|
| 14 |
Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer
|
Pei, Fengyun
|
|
|
22 |
1 |
p. 85-91
|
article
|
| 15 |
Stereotactic Ablative Radiation Therapy for Colorectal Liver Metastases
|
McDermott, Ronan L
|
|
|
22 |
1 |
p. 120-128
|
article
|
| 16 |
Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis
|
Ouyang, Huaqiang
|
|
|
22 |
1 |
p. 111-119
|
article
|
| 17 |
Systemic Therapy for Pancreatic Neuroendocrine Tumors
|
Wheless, Margaret
|
|
|
22 |
1 |
p. 34-44
|
article
|
| 18 |
Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine
|
Ayasun, Ruveyda
|
|
|
22 |
1 |
p. 2-11
|
article
|
| 19 |
Table of contents
|
|
|
|
22 |
1 |
p. A3-A5
|
article
|
| 20 |
The Current Role of Radiation in Pancreatic Cancer and Future Directions
|
Hill, Colin S.
|
|
|
22 |
1 |
p. 12-23
|
article
|
| 21 |
Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data
|
Sakamoto, Yasutoshi
|
|
|
22 |
1 |
p. 45-52
|
article
|
| 22 |
Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient
|
Copur, Mehmet Sitki
|
|
|
22 |
1 |
p. 160-165
|
article
|
Journal description